Iuliia Makarenko
Biographic Data
| ID | 6652774 |
|---|---|
| NAME | Iuliia Makarenko |
| GIVEN NAMES | Iuliia |
| FAMILY NAME | Makarenko |
| SIGNATURE | MAKARENKO I |
| AFFILIATIONS | Centre Hospitalier de l’Université de Montréal |
| ORCID | 0000-0001-6963-4368 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 7 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Measurement of Impulsivity and Its Role in Drug Use Behaviours and Related Health, Harm and Treatment Outcomes Among People Who Use Illicit Drugs—A Scoping Review
Impulsivity is closely implicated in substance use disorders; however, its definition and assessment among people who use illicit drugs (PWUD) are lacking consistency. This scoping review maps the existing evidence on how impulsivity has been defined, measured, and linked to drug use behaviours and consequences. A systematic search of manuscripts (1990–2025) was conducted across multiple databases, identifying 267 eligible studies. Behavioural ta…
Determinants of psychological distress during the Covid ‐19 pandemic among people who use drugs in Montreal, Canada
HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers
Treatment initiation rates have increased since the introduction of universal DAA coverage, though barriers such as incarceration persist
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to Covid-19
BACKGROUND: "Big Events" are major disruptions to physical, political, and economic environments that can influence vulnerability to drug-related harms. We reviewed the impacts of Big Events with relevance to the COVID-19 pandemic on drug-related risk and harms and access to drug treatment and harm reduction services. METHODS: We conducted a rapid review of quantitative, qualitative, and mixed methods literature relating to the following Big Even…
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs
Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine
Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007–2013
No prominent works on this page.
Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine
Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007–2013
Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to Covid-19
BACKGROUND: "Big Events" are major disruptions to physical, political, and economic environments that can influence vulnerability to drug-related harms. We reviewed the impacts of Big Events with relevance to the COVID-19 pandemic on drug-related risk and harms and access to drug treatment and harm reduction services. METHODS: We conducted a rapid review of quantitative, qualitative, and mixed methods literature relating to the following Big Even…
HCV treatment initiation in the era of universal direct acting antiviral coverage – Improvements in access and persistent barriers
Treatment initiation rates have increased since the introduction of universal DAA coverage, though barriers such as incarceration persist
Determinants of psychological distress during the Covid ‐19 pandemic among people who use drugs in Montreal, Canada
Measurement of Impulsivity and Its Role in Drug Use Behaviours and Related Health, Harm and Treatment Outcomes Among People Who Use Illicit Drugs—A Scoping Review
Impulsivity is closely implicated in substance use disorders; however, its definition and assessment among people who use illicit drugs (PWUD) are lacking consistency. This scoping review maps the existing evidence on how impulsivity has been defined, measured, and linked to drug use behaviours and consequences. A systematic search of manuscripts (1990–2025) was conducted across multiple databases, identifying 267 eligible studies. Behavioural ta…
HIV, Drug Use, Sexual Risk (6 works) · Medicine (6 works) · Demography (5 works) · Internal Medicine (5 works) · Demography (4 works) · Environmental health (4 works) · Logistic regression (4 works) · Opioid Use Disorder Treatment (4 works) · Substance Abuse Treatment and Outcomes (4 works) · Psychiatry (3 works)